Back
Atossa Therapeutics Stock Price Chart
Sponsored
ATOS
Sponsored
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.
Buy
56
ATOS
Atossa Therapeutics
Last Price:
1.42
Seasonality Move:
-17.86%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.- The current trend is moderately bearish and ATOS is experiencing selling pressure, which indicates risk of future bearish movement.
Atossa Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.45 | Buy |
20-day SMA: | 1.44 | Buy |
50-day SMA: | 1.41 | Buy |
200-day SMA: | 1.32 | Buy |
8-day EMA: | 1.46 | Buy |
20-day EMA: | 1.44 | Buy |
50-day EMA: | 1.41 | Buy |
200-day EMA: | 1.29 | Buy |
Atossa Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 52.93 | Buy |
Chaikin Money Flow: | -189357 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.4 - 1.48) | Buy |
Bollinger Bands (100): | (1.21 - 1.45) | Buy |
Atossa Therapeutics Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Atossa Therapeutics Stock
Is Atossa Therapeutics Stock a Buy?
- Atossa Therapeutics share price is 1.46 while ATOS 8-day simple moving average is 1.45, which is a Buy signal.
- The stock price of ATOS is 1.46 while Atossa Therapeutics 20-day SMA is 1.44, which makes it a Buy.
- Atossa Therapeutics 50-day simple moving average is 1.41 while ATOS share price is 1.46, making it a Buy technically.
- ATOS stock price is 1.46 and Atossa Therapeutics 200-day simple moving average is 1.32, creating a Buy signal.
ATOS Technical Analysis vs Fundamental Analysis
Buy
56
Atossa Therapeutics (ATOS)
is a Buy
Is Atossa Therapeutics a Buy or a Sell?
-
Atossa Therapeutics stock is rated a Buy
The current Atossa Therapeutics [ATOS] share price is $1.46. The Score for ATOS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Atossa Therapeutics Stock Info
Market Cap:
183.61M
Price in USD:
1.46
Share Volume:
315.6K
Atossa Therapeutics 52-Week Range
52-Week High:
2.31
52-Week Low:
0.62
Buy
56
Atossa Therapeutics (ATOS)
is a Buy
Atossa Therapeutics Share Price Forecast
-
What is the Atossa Therapeutics stock price today?
The Atossa Therapeutics stock price is 1.46 USD today. -
Will ATOS stock go up or go down?
Atossa Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Atossa Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atossa Therapeutics is not overvalued.
Is Atossa Therapeutics Stock a Buy?
- Atossa Therapeutics share price is 1.46 while ATOS 8-day exponential moving average is 1.46, which is a Buy signal.
- The stock price of ATOS is 1.46 while Atossa Therapeutics 20-day EMA is 1.44, which makes it a Buy.
- Atossa Therapeutics 50-day exponential moving average is 1.41 while ATOS share price is 1.46, making it a Buy technically.
- ATOS stock price is 1.46 and Atossa Therapeutics 200-day simple moving average is 1.29, creating a Buy signal.
Fundamental Analysis of Atossa Therapeutics
Is Atossa Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Atossa Therapeutics
Should I short Atossa Therapeutics stock?
- ATOS Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Atossa Therapeutics is a Buy
- Atossa Therapeutics Relative Strength Index (RSI) is 52.93, which suggest Atossa Therapeutics is overbought
- The Bollinger Bands (25) for Atossa Therapeutics is (1.4 - 1.48), which suggest Atossa Therapeutics is a Buy
- The Bollinger Bands (100) for Atossa Therapeutics is (1.21 - 1.45), which suggest Atossa Therapeutics is a Buy
* Atossa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.